OOIR: Observatory of International Research

Papers

(The H4-Index of European Journal of Pharmaceutical Sciences is 37. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Integrated models of population pharmacokinetics and exposure response to optimize dosage regimen for anaprazole sodium in duodenal ulcer	427
Impact of therapeutic drug monitoring on microbiological eradication in patients with staphylococcus aureus bacteremia	175
CYP2E1 mediated advanced oxidation protein products exacerbate acetaminophen induced drug-derived liver injury in vitro and in vivo	139
Development of Imiquimod-induced HaCaT-THP-1 co-culture for modeling of psoriasis	134
Targeting fusion proteins of the interleukin family: A promising new strategy for the treatment of autoinflammatory diseases	121
Editorial Board	99
Nitrite testing in excipients – Industry best practices	97
Molecular characteristics of several drugs evaluated from solvent/water partition measurements: Solvation parameters and intramolecular hydrogen bond indicator	94
Development of a new inhaled swellable microsphere system for the dual delivery of naringenin-loaded solid lipid nanoparticles and doxofylline for the treatment of asthma	85
Natural borneol serves as an adjuvant agent to promote the cellular uptake of piperlongumine for improving its antiglioma efficacy	81
Pre-miRNA-149 G-quadruplex as a molecular agent to capture nucleolin	78
Esomeprazole prevents oxaliplatin-induced peripheral neuropathy through inhibiting organic cation transporter 2 in mice	71
Evaluating the influence of the initial high molecular weight level on monoclonal antibody particle formation kinetics using a short-term chemical stress study	68
In vitro identification of decreased function genetic variants of ABCB1	63
Biophysical and permeability characterization of lyophilized (freeze-dried) human cadaver skin	61
Epigenetic therapeutics attenuate kidney injury and fibrosis by restoring the expression of epigenetically reprogrammed fibrogenic genes and signaling pathways	60
3D printed extended-release hydrochlorothiazide tablets	54
Soft mist inhaler nebulization by Rayleigh-breakup largely preserves functional integrity of liposomal mRNA in respirable aerosols	51
Effect of process parameters in high shear granulation on characteristics of a novel co-processed mesoporous silica material	51
Probing O-substituted nifuroxazide analogues against Leishmania: Synthesis, in vitro efficacy, and hit/lead identification	50
Highly cationic cell-penetrating peptides affect the barrier integrity and facilitates mannitol permeation in a human stem cell-based blood-brain barrier model	49
Drug diffusion in biomimetic hydrogels: importance for drug transport and delivery in non-vascular tumor tissue	48
VA1213, a selective COX-2 inhibitor, exhibits antitumor activity by suppressing EGFR, AKT, and ERK1/2 phosphorylation	45
Evaluation of the increase of the thymoquinone permeability formulated in polymeric micelles: In vitro test and in vivo toxicity assessment in Zebrafish embryos	44
Evaluating rat and canine microbiota models for predicting human colonic prodrug metabolism	42

Impact of protein adsorption during biopharmaceutical manufacture & storage	42
Impact of drug load and polymer molecular weight on the 3D microstructure of printed tablets	41
Microparticles and multi-unit systems for advanced drug delivery	41
The effect of formulation composition and flow conditions on the robustness of semisolid extrusion 3D printing: a case study on poorly water-soluble itraconazole for oral dosage form production	40
Opportunities of topical drug products in a changing dermatological landscape	39
Dissolving microneedles with antibacterial functionalities: A systematic review of laboratory studies	39
Intranasal propranolol hydrochloride-loaded PLGA-lipid hybrid nanoparticles for brain targeting: Optimization and biodistribution study by radiobiological evaluation	39
Development of a thermosensitive hydrogel based on Polaxamer 407 and gellan gum with inclusion complexes (Sulfobutylated-β-cyclodextrin–Farnesol) as a local drug delivery system	38
Controlled release and extended pulmonary retention of inhaled therapeutics: A review	38
iRGD mediated pH-responsive mesoporous silica enhances drug accumulation in tumors	37
Dose finding for ZSP1601 in patients with nonalcoholic steatohepatitis using population pharmacokinetics and exposure–response approach	37
A new nanosuspension prepared with wet milling method for oral delivery of highly variable drug Cyclosporine A: development, optimization and in vivo evaluation	37
Optimization, characterization and in vivo evaluation of mupirocin nanocrystals for topical administration	37